Suchergebnisse - "Spahn, Viola"

PubPharm (19)

1

Analgesic effects of a novel pH-dependent μ-opioid receptor agonist in models of neuropathic and abdominal pain

enthalten in: Pain | 2018

von Rodriguez-Gaztelumendi, A. | Spahn, V. | Labuz, D. | +2

2

Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist

enthalten in: Scientific reports | 2018

von Spahn, V. | Del Vecchio, G. | Rodriguez-Gaztelumendi, A. | +7

CommentIn: Lancet. 2019 Apr 20;393(10181):1579-1581. - PMID 31007186

3

Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons - Effects of Nerve Injury

enthalten in: Frontiers in pharmacology | 2018

von Stötzner, P. | Spahn, V. | Celik, M. | +2

4

Production of G protein-coupled receptors in an insect-based cell-free system

enthalten in: Biotechnology and bioengineering | 2017

von Sonnabend, A. | Spahn, V. | Stech, M. | +3

5

Novel Opioid Analgesics and Side Effects

enthalten in: ACS chemical neuroscience | 2017

von Del Vecchio, G. | Spahn, V. | Stein, C.

6

Polyglycerol-opioid conjugate produces analgesia devoid of side effects

enthalten in: eLife | 2017

von González-Rodríguez, S. | Quadir, M. | Gupta, S. | +11

7

Targeting delta opioid receptors for pain treatment : drugs in phase I and II clinical development

enthalten in: Expert opinion on investigational drugs | 2017

von Spahn, V. | Stein, C.

8

Targeting delta opioid receptors for pain treatment: drugs in phase I and II clinical development

enthalten in: Expert opinion on investigational drugs | 2017

von Spahn, V. | Stein, C.

9

Targeting delta opioid receptors for pain treatment: drugs in phase I and II clinical development

enthalten in: Expert opinion on investigational drugs | 2017

von Spahn, V. | Stein, C.

10

Production of G protein‐coupled receptors in an insect‐based cell‐free system

enthalten in: Biotechnology and bioengineering | 2017

von Sonnabend, A. | Spahn, V. | Stech, M. | +3